Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy

Ítems similars

• Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy
  per: Van Ry, Pam M., et al.
  Publicat: (2014)
• Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A
  per: Doe, Jinger A., et al.
  Publicat: (2011)
• Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy
  per: Rooney, Jachinta E., et al.
  Publicat: (2009)
• Laminin-111 Restores Regenerative Capacity in a Mouse Model for α7 Integrin Congenital Myopathy
  per: Rooney, Jachinta E., et al.
  Publicat: (2009)
• Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy
  per: Barraza-Flores, Pamela, et al.
  Publicat: (2019)